Skip to content

The ESMO Deep Dive Webinar Series provides advanced knowledge in the tumour type, allowing deep understanding of disease biology, areas of controversy and unmet need.   

Designed to deliver the oncologist a second, deeper  layer of permeative, educational experience in cancer profiling and precision management, the series aims to better equip health professionals for informed, innovative thinking and engagement in ongoing and future research. Designed for oncologists with a background knowledge of the tumour.
4096-2731-max

ABOUT THE WEBINAR SERIES

ESMO Guidelines Webinar series_ Cover-strong
climb-chart-2
An advanced level Deep Dive into areas of controversy, unmet need, active research and breakthroughs
ESMO Guidelines Webinar series_ Cover-strong
Group 1000001783
The faculty consists of four speakers, identified among world acknowledged key investigators and thought leaders
ESMO Guidelines Webinar series_ Cover-strong
qna-deepdive
Each 90 minute webinar includes interactive, live presentations, discussion and Q&A
ESMO Guidelines Webinar series_ Cover-strong
Icon_Onair
Webinars take place on a Wednesday through the ESMO On Air initiative

This webinar series is multi-sponsored per series

 

 

ESMO DEEP DIVE WEBINAR SERIES 2026: GYNAECOLOGICAL CANCERS

ESMO Guidelines Webinar series_ Cover-strong3

The Challenge of First-line Therapy for Patients with HRD Negative Advanced Ovarian Cancer

SEPTEMBER 2026
IsabelleRay-Coquard
Isabelle Ray-Coquard

France (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

The Evolving Landscape in the Treatment of Relapse Ovarian Cancer

OCTOBER 2026
SusanaBanerjee
Susana Banerjee

UK (Chair)

ESMO Guidelines Webinar series_ Cover-strong

Are We Defeating Cervical Cancer?

NOVEMBER 2026

DomenicoLorusso
Domenica Lorusso

Italy (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

Is Molecular Classification Leading to Indvidualised Therapy in Endometrial Cancer?

DECEMBER 2026
AnaOaknin
Ana Oaknin

Spain (Chair)

ESMO DEEP DIVE WEBINAR SERIES 2026: GENITOURINARY CANCERS

ESMO Guidelines Webinar series_ Cover-strong3

Multimodal Therapy in MIBC: From Established Standard to Future Directions

FEBRUARY 2026
ViktorGrunwald
Viktor Grünwald

Germany (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

Beyond Cure:  Optimising Medical Care in Metastatic Bladder Cancer 

MARCH 2026
ViktorGrunwald
Viktor Grünwald

Germany (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics

APRIL 2026
ViktorGrunwald
Viktor Grünwald

Germany (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

Improving Outcomes in High-Risk Localised Prostate Cancer

MAY 2026

DeborahMukherji
Deborah Mukherji

United Arab Emirates (Chair)

ESMO Guidelines Webinar series_ Cover-strong3

Metastatic Castration-Resistant Prostate Cancer

JULY 2026

AureliusOmlin
Aurelius Omlin

Switzerland (Chair)

BENEFITS FOR OUR PARTNERS

EXTENSIVE COMPANY/LOGO RECOGNITION
WEBINAR HOSTED ON-DEMAND ON ONCOLOGYPRO FOR 2 YEARS
FULL OUTCOMES REPORT INCLUDING LIVE AND ON-DEMAND METRICS
LOREM IPSUM DOLOR SIT AMET LOREM IPSUM

FUNDING OPTIONS

Support type
Funding amount per sponsor (EUR)
Multi-sponsored €50,000 per series

ESMO DEEP DIVE WEBINAR SERIES 2025 - STATISTICS

PARTICIPANTS

594

Countries & Territories

57

Oncology Clinicians

58.7%

Abstracts presented

121

Programme Speakers

66

Image 1
Image 2
Image3
ESMO Guidelines Webinar series_ Cover-strong2

Download the prospectus to find out about sponsorship and funding opportunities

SUPPORTERS OF THE ESMO DEEP DIVE WEBINAR SERIES 2025 - LUNG CANCER

Boehringer
Daiichi
Gilead
Johnson&Johnson
Lilly
ESMO-Menarini
Roche-1

SUPPORTERS OF THE ESMO DEEP DIVE WEBINAR SERIES 2024 – BREAST CANCER

Daiichi
Astra_Zeneca
Gilead
Lilly
MSD-1
Novartis

ESMO Deep Dive Webinar Series enquiry form

Please fill out this form to get in touch with us for questions related to ESMO Deep Dive Webinar Series